QAM
IBB icon

Questar Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

Questar Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-16,231
Closed -$1.56M – 38
2018
Q4 		$1.56M Buy
+16,231
New +$1.72M 1.84% 17

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
N
Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

Questar Asset Management's IBB Position: Q1 2019 in Review

Questar Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 16,231 shares — an estimated $1.56M sold.

Questar Asset Management first reported a position in IBB in Q4 2018 and held it in 1 quarter. The position peaked at $1.56M in Q4 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

  • Questar Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
  • Questar Asset Management sold 16,231 iShares Biotechnology ETF shares in Q1 2019, an estimated $1.56M.
  • Questar Asset Management first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 1 quarter.
  • Questar Asset Management's iShares Biotechnology ETF position peaked at $1.56M in Q4 2018.
  • 670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Questar Asset Management's 13F filing for Q1 2019.